Get the app
US › Healthcare

Embecta Corp (EMBC)

US · Healthcare · Medical Instruments & Supplies

$5.19+1.17%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$271.7M
Revenue YoY
-8.1%
Net profit
$21.1M
Profit YoY
-53.6%
EPS
$0.56
EPS estimate
$0.26
Net margin
7.8%

EPS came in at 0.56 against a street estimate of 0.26 — a beat of 115.4%.

Key statistics

Market cap
$277.1M
P/E
3.5
Forward P/E
0.0
P/B
2.61
Book value
$-10.81
EPS (TTM)
$1.41
Dividend yield
8.98%
52-week high
$15.05
52-week low
$2.76
50-day MA
$4.24
200-day MA
$7.57
Beta
0.85

Analyst view

Analysts rate Embecta Corp a hold (1 buy, 3 hold, 1 sell out of 5) with an average price target of $4.00.

Shareholding

Insiders
2.01%
Institutions
92.38%

Largest institutional holders

FundStake
BlackRock Inc16.18%
Yacktman Asset Management Co7.62%
Vanguard Capital Management, LLC4.53%
State Street Corp4.49%
Deerfield Management Co4.47%
Jefferies Financial Group Inc4.16%
Vanguard Portfolio Management, LLC2.71%
Brigade Capital Management LP2.68%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Embecta Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.